Jill Koshiol | |
|---|---|
 | |
| Alma mater | UNC Gillings School of Global Public Health |
| Scientific career | |
| Fields | Cancer epidemiology |
| Institutions | National Cancer Institute |
| Website | jillkoshiol |
Jill E. Koshiol is an American cancer epidemiologist who researches the risk factors of hepatobiliary cancers. She is a senior investigator in the infections and immunoepidemiology branch at the National Cancer Institute.
Koshiol received a Ph.D. in epidemiology from the UNC Gillings School of Global Public Health in 2005. [1] Her dissertation was titled, Effect of smoking and human papillomavirus (HPV) type on time to clearance of HPV infection among HIV-seropositive and HIV-seronegative women. [2] Jane C. Schroeder was her doctoral advisor. [2] In 2005, Koshiol joined the National Cancer Institute (NCI)'s genetic epidemiology branch of the division of cancer epidemiology and genetics as a cancer prevention fellow. [1]
Koshiol joined the NCI infections and immunoepidemiology branch as a research fellow in 2008, became an Earl Stadtman Tenure-Track Investigator in 2010, and was awarded National Institutes of Health (NIH) scientific tenure and promoted to senior investigator in 2020. [1] Koshiol received the Hubert H. Humphrey Award for Service to America in 2022. [1] She researches hepatobiliary cancers and identifies risk factors, such as aflatoxin. [1]
Cervical cancer is a cancer arising from the cervix. It is due to the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Early on, typically no symptoms are seen. Later symptoms may include abnormal vaginal bleeding, pelvic pain or pain during sexual intercourse. While bleeding after sex may not be serious, it may also indicate the presence of cervical cancer.
Human papillomavirus infection is caused by a DNA virus from the Papillomaviridae family. Many HPV infections cause no symptoms and 90% resolve spontaneously within two years. In some cases, an HPV infection persists and results in either warts or precancerous lesions. These lesions, depending on the site affected, increase the risk of cancer of the cervix, vulva, vagina, penis, anus, mouth, tonsils, or throat. Nearly all cervical cancer is due to HPV, and two strains – HPV16 and HPV18 – account for 70% of all cases. HPV16 is responsible for almost 90% of HPV-positive oropharyngeal cancers. Between 60% and 90% of the other cancers listed above are also linked to HPV. HPV6 and HPV11 are common causes of genital warts and laryngeal papillomatosis.
Anal cancer is a cancer which arises from the anus, the distal opening of the gastrointestinal tract. Symptoms may include bleeding from the anus or a lump near the anus. Other symptoms may include pain, itchiness, or discharge from the anus. A change in bowel movements may also occur.
Cervical intraepithelial neoplasia (CIN), also known as cervical dysplasia, is the abnormal growth of cells on the surface of the cervix that could potentially lead to cervical cancer. More specifically, CIN refers to the potentially precancerous transformation of cells of the cervix.
Anna-Lise WilliamsonMASSAf is a Professor of Virology at the University of Cape Town. Williamson obtained her PhD from the University of the Witwatersrand in 1985. Her area of expertise is human papillomavirus, but is also known on an international level for her work in developing vaccines for HIV. These vaccines have been introduce in phase 1 of clinical trial. Williamson has published more than 120 papers.
Lauren V. Wood is an American allergist, immunologist, and staff physician at the National Cancer Institute (NCI) at the National Institutes of Health (NIH) in Bethesda, Maryland, where she has served as a principal investigator. She is known for conducting studies of vaccines for cancer, Human papillomavirus (HPV), Hepatitis C, and HIV especially for use with children, teens and young adults. She holds the rank of captain in the U.S. Public Health Service (PHS).
Gypsyamber D'Souza is an American epidemiologist. She is a professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health. D'Souza researches infectious diseases, cancer prevention, and translational epidemiology. She is a principal investigator of the Multicenter AIDS Cohort Study / Women's Interagency HIV Study Combined Cohort Study (Mwccs.org).
Xiaohong Rose Yang is an American biomedical scientist researching the genetics of dysplastic nevus syndrome and chordoma, and etiologic heterogeneity of breast cancer. She is a senior investigator at the National Cancer Institute. Yang leads breast cancer studies in mainland China, Hong Kong, and Malaysia.
Maura Lianne Gillison is an American medical oncologist and molecular epidemiologist. She is credited as the first investigator to establish a connection between HPV and oral cancer.
Rachael Zoe Stolzenberg-Solomon is an American epidemiologist and dietitian. She is a senior investigator and head of the metabolic epidemiology branch at the National Cancer Institute.
Megan A. Clarke is an American cancer epidemiologist who researches anogenital and endometrial cancers. She is a Stadtman investigator in the clinical genetics branch at the National Cancer Institute.
Julia C. Gage is an American cancer epidemiologist who researches cervical screening and the human papillomavirus infection. She is a staff scientist in the clinical genetics branch at the National Cancer Institute.
Lisa J. Mirabello is an American medical geneticist who researches genetic susceptibility to pediatric cancer and the genomics of HPV carcinogenicity. She is a senior investigator in the clinical genetics branch at the National Cancer Institute.
Aimée Rebecca Kreimer is an American cancer epidemiologist who researches the etiology and prevention of human papillomavirus infection (HPV) and cancer prevention. She is a senior investigator in the infections and immunoepidemiology branch at the National Cancer Institute.
Sam M. Mbulaiteye is a Ugandan physician-scientist and epidemiologist who researches Burkitt lymphoma. He is a senior investigator at the National Cancer Institute.
Meredith Sarah Shiels is an American cancer epidemiologist who researches cancer risks in people with HIV. She is a senior investigator at the National Cancer Institute.
María Constanza Camargo Bohórquez is a Colombian cancer epidemiologist who researches the Epstein–Barr virus and gastric carcinogenesis. She is an investigator in the metabolic epidemiology branch at the National Cancer Institute.
Wen-Yi Huang is a cancer epidemiologist who primarily researches colorectal and prostate tumors. She is a staff scientist in the metabolic epidemiology branch at the National Cancer Institute.
Sonja Ingrid Berndt is an American pharmacologist and cancer epidemiologist who researches non-Hodgkin lymphoma, prostate cancer, and anthropometric traits that are cancer risk factors. She is a senior investigator in the occupational and environmental epidemiology branch at the National Cancer Institute.
Lindsay McOmber Morton is an American cancer epidemiologist who researches genetic susceptibility to second cancers. She is the acting chief of the radiation epidemiology branch and head of its cancer survivorship research unit at the National Cancer Institute.
This article incorporates text from this source, which is in the public domain . This article incorporates public domain material from websites or documents of the National Institutes of Health.| Authority control databases: Academics |
|---|
